In the first government-backed survey conducted since Gardasil, the vaccination against the human papillomavirus (HPV), made its market debut in 2006, the Centers for Disease Control and Prevention (CDC) says about 25% of all American girls between the ages of…

In 2006, the US Food and Drug Administration (FDA) approved the vaccine, Gardasil, for girls and women between the ages of 9 and 26 as a means of preventing cervical cancer caused by the human papillomavirus (HPV).  In a September…

During 2007, more than 11,000 women in the United States were diagnosed with cervical cancer. Another 3,600 women died from it. The recently introduced Gardasil vaccine is expected to reduce the incidence of cervical cancer but it is most effective…

Jenny was a healthy, happy 13-year-old from Northern California until about 15 months ago when signs of muscle deterioration began appearing.  At that time, she’d also completed the third and final dose of Gardasil, the vaccine given to guard against…

Merck & Co., Inc., has announced that the US Food and Drug Administration (FDA) has accepted and designated as priority a review of GARDASIL, a vaccine against types 6, 11, 16, and 18 of the human papillomavirus (HPV), which is…

A new study shows that the HPV vaccine, GARDASIL, reduced abnormal Pap test results by 43 percent compared to women not given the vaccine. GARDASIL is FDA approved against the human papilloma virus (HPV) strains (6, 11, 16, 18) believed…

According to new research, Human Papillomavirus (HPV) may be responsible for the development of oral cancer in men to a greater extent than previously thought. Statistics show that in the past four decades, incidence of oral cancer caused by HPV…

MedHeadlines - Two young women have died shortly after receiving Gardasil, a vaccine against human papillomavirus - one of the main causes of cervical cancer. The European Medicines Agency (EMEA) has reported that the two deaths occurred in Austria and…